Correlation Between OncoSec Medical and Cyclacel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both OncoSec Medical and Cyclacel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OncoSec Medical and Cyclacel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OncoSec Medical and Cyclacel Pharmaceuticals, you can compare the effects of market volatilities on OncoSec Medical and Cyclacel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OncoSec Medical with a short position of Cyclacel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of OncoSec Medical and Cyclacel Pharmaceuticals.
Diversification Opportunities for OncoSec Medical and Cyclacel Pharmaceuticals
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between OncoSec and Cyclacel is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding OncoSec Medical and Cyclacel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclacel Pharmaceuticals and OncoSec Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OncoSec Medical are associated (or correlated) with Cyclacel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclacel Pharmaceuticals has no effect on the direction of OncoSec Medical i.e., OncoSec Medical and Cyclacel Pharmaceuticals go up and down completely randomly.
Pair Corralation between OncoSec Medical and Cyclacel Pharmaceuticals
Given the investment horizon of 90 days OncoSec Medical is expected to under-perform the Cyclacel Pharmaceuticals. In addition to that, OncoSec Medical is 1.91 times more volatile than Cyclacel Pharmaceuticals. It trades about -0.29 of its total potential returns per unit of risk. Cyclacel Pharmaceuticals is currently generating about -0.06 per unit of volatility. If you would invest 1,020 in Cyclacel Pharmaceuticals on August 31, 2024 and sell it today you would lose (979.00) from holding Cyclacel Pharmaceuticals or give up 95.98% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 8.56% |
| Values | Daily Returns |
OncoSec Medical vs. Cyclacel Pharmaceuticals
Performance |
| Timeline |
| OncoSec Medical |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Cyclacel Pharmaceuticals |
OncoSec Medical and Cyclacel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with OncoSec Medical and Cyclacel Pharmaceuticals
The main advantage of trading using opposite OncoSec Medical and Cyclacel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OncoSec Medical position performs unexpectedly, Cyclacel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclacel Pharmaceuticals will offset losses from the drop in Cyclacel Pharmaceuticals' long position.| OncoSec Medical vs. ZyVersa Therapeutics | OncoSec Medical vs. Palisade Bio | OncoSec Medical vs. Unicycive Therapeutics | OncoSec Medical vs. Immix Biopharma |
| Cyclacel Pharmaceuticals vs. Eliem Therapeutics | Cyclacel Pharmaceuticals vs. Ikena Oncology | Cyclacel Pharmaceuticals vs. Ovid Therapeutics | Cyclacel Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |